Business Standard

Pharma exports may return to double digit-growth rate: Pharmexcil

Drug shortages in US and EU, revival in Africa key drivers

Uday Bhaskar
Premium

Uday Bhaskar, director general, Pharmexcil

Sohini Das Mumbai

Listen to This Article

Owing to drug shortages in the US and Europe and revival in demand in Africa, pharmaceutical exports from India are likely to touch $28 billion in 2023-24, registering 10.2 per cent growth, said a senior official at the Pharmaceutical Export Promotion Council (Pharmexcil).
 
India’s pharma exports grew 3.2 per cent in FY23 to $25.4 billion, led primarily by Europe and the US.
Exports to countries such as Zambia, Nigeria, Zimbabwe, and Burkina Faso dipped, bringing down shipments to the African region by 5.4 per cent.
 
However, between April and October this year pharma exports grew 8.13 per cent to about $15.8

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in